Cutler Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $9K | Sell |
29,400
-210,600
| -88% | -$5.84M | ﹤0.01% | 1332 |
|
|
2023
Q4 | $283K | Buy |
240,000
+6,800
| +3% | +$206K | 0.03% | 601 |
|
|
2023
Q3 | $163K | Buy |
233,200
+137,400
| +143% | +$4.86M | 0.02% | 853 |
|
|
2023
Q2 | $260K | Buy |
95,800
+100
| +0.1% | +$3.89K | 0.04% | 522 |
|
|
2023
Q1 | $278K | Buy |
95,700
+30,100
| +46% | +$1.3M | 0.03% | 544 |
|
|
2022
Q4 | $107K | Sell |
65,600
-35,300
| -35% | -$1.69M | 0.01% | 1124 |
|
|
2022
Q3 | $338K | Sell |
100,900
-133,500
| -57% | -$6.49M | 0.02% | 707 |
|
|
2022
Q2 | $252K | Sell |
234,400
-404,100
| -63% | -$20.6M | 0.02% | 878 |
|
|
2022
Q1 | $850K | Buy |
638,500
+348,200
| +120% | +$18.1M | 0.04% | 443 |
|
|
2021
Q4 | $185K | Sell |
290,300
-413,300
| -59% | -$20.5M | 0.01% | 1386 |
|
|
2021
Q3 | $1.31M | Buy |
703,600
+440,500
| +167% | +$19.5M | 0.06% | 366 |
|
|
2021
Q2 | $91K | Buy |
263,100
+162,200
| +161% | +$6.31M | ﹤0.01% | 1968 |
|
|
2021
Q1 | $177K | Sell |
100,900
-188,700
| -65% | -$6.7M | 0.01% | 1357 |
|
|
2020
Q4 | $319K | Buy |
289,600
+100,829
| +53% | +$3.7M | 0.02% | 844 |
|
|
2020
Q3 | $274K | Sell |
188,771
-10,646
| -5% | -$373K | 0.02% | 777 |
|
|
2020
Q2 | $469K | Sell |
199,417
-48,168
| -19% | -$1.64M | 0.03% | 512 |
|
|
2020
Q1 | $876K | Buy |
247,585
+182,869
| +283% | +$6.23M | 0.05% | 377 |
|
|
2019
Q4 | $200K | Buy |
64,716
+2,108
| +3% | +$75.1K | 0.01% | 822 |
|
|
2019
Q3 | $335K | Buy |
62,608
+44,374
| +243% | +$1.61M | 0.03% | 482 |
|
|
2019
Q2 | $15K | Buy |
+18,234
| New | +$724K | ﹤0.01% | 2409 |
|
|
2018
Q4 | – | Sell |
-66,297
| Closed | -$2K | – | 4437 |
|
|
2018
Q3 | $2K | Hold |
66,297
| – | – | ﹤0.01% | 3545 |
|
|
2018
Q2 | $22K | Hold |
66,297
| – | – | ﹤0.01% | 2134 |
|
|
2018
Q1 | $62K | Sell |
66,297
-36,257
| -35% | -$1.25M | 0.01% | 1511 |
|
|
2017
Q4 | $54K | Sell |
102,554
-35,520
| -26% | -$1.21M | ﹤0.01% | 1800 |
|
|
2017
Q3 | $112K | Buy |
138,074
+40,684
| +42% | +$1.31M | ﹤0.01% | 1581 |
|
|
2017
Q2 | $119K | Buy |
97,390
+14,335
| +17% | +$452K | ﹤0.01% | 1717 |
|
|
2017
Q1 | $65K | Sell |
83,055
-137,020
| -62% | -$4.32M | ﹤0.01% | 2129 |
|
|
2016
Q4 | $297K | Buy |
220,075
+87,166
| +66% | +$2.66M | 0.01% | 1031 |
|
|
2016
Q3 | $72K | Buy |
132,909
+109,932
| +478% | +$3.68M | ﹤0.01% | 2114 |
|
|
2016
Q2 | $9K | Sell |
22,977
-215,122
| -90% | -$6.87M | ﹤0.01% | 4288 |
|
|
2016
Q1 | $204K | Sell |
238,099
-48,062
| -17% | -$1.37M | 0.01% | 1006 |
|
|
2015
Q4 | $90K | Buy |
+286,161
| New | +$9M | 0.01% | 1888 |
|
Other funds holding PFE
Cutler Group's PFE Position: Q1 2024 in Review
Cutler Group reduced its Pfizer (PFE) stake by 92% in Q1 2024, selling an estimated $3.36M and leaving 10,075 shares worth $279K. The position accounts for 0.09% of the portfolio, ranked #216.
Cutler Group first reported a position in PFE in Q4 2015 and has held it in 33 quarters since. The position peaked at $10.8M in Q1 2022. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Cutler Group held 10,075 shares of Pfizer worth $279K as of Q1 2024.
- Cutler Group sold 120,937 Pfizer shares in Q1 2024, an estimated $3.36M.
- Pfizer made up 0.09% of Cutler Group's portfolio in Q1 2024, its #216 holding.
- Cutler Group first reported a position in Pfizer in Q4 2015 and has held it in 33 quarters since.
- Cutler Group's Pfizer position peaked at $10.8M in Q1 2022.
- 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.